The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. The metric has seen a significant gain of 193.68% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 63.16%. Over the past 30 days, the price of ATHE has fallen by 42.35%. And in the last five days, it has surged by 13.88%.
The stock of Alterity Therapeutics Ltd ADR (ATHE) is currently priced at $5.58. In the last session, the stock climbed significantly, topping out at $12.0 after opening at $5.58. The day’s lowest price was $10.0 before the stock closed at $6.55.
Alterity Therapeutics Ltd ADR’s market performance has been stable in recent times. The company’s stock hit a 1-year high of $7.00 on 07/25/25 and a low of $1.00 for the same time frame on 11/22/24.
52-week price history of ATHE Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Alterity Therapeutics Ltd ADR’s current trading price is -20.29% away from its 52-week high, while its distance from the 52-week low is 457.44%. The stock’s price range during this period has varied between$1.00 and $7.00. The Alterity Therapeutics Ltd ADR’s shares, which operate in the Healthcare, saw a trading volume of around 1.88 million for the day, a figure considerably higher than their average daily volume of 70880.0 over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Alterity Therapeutics Ltd ADR (ATHE) has experienced a quarterly rise of 60.32% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 85.65M and boasts a workforce of 10 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 4.02, with a change in price of +2.02. Similarly, Alterity Therapeutics Ltd ADR recorded 69,415 in trading volume during the last 100 days, posting a change of +56.74%.
ATHE’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ATHE stands at 0.01. Similarly, the long-term debt-to-equity ratio is also 0.01.
ATHE Stock Stochastic Average
Alterity Therapeutics Ltd ADR’s raw stochastic average for the past 50 days is presently 56.84%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 56.04%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 78.27% and 80.75%, respectively.
